BPA Call 36E79721A0026-36C25022N0640
Award Date
6/15/22
Potential Completion Date
9/30/22
Potential Value
$105K
Federal Agency
Veterans Integrated Service Network 10
Awardee
Sobi, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of emergency medication to the Department of Veterans Affairs (VA) Syracuse Medical Center, specifically for the Veterans Integrated Service Network (VISN) 2 region. The contract was awarded to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. Takeda Pharmaceuticals America is a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, based in Japan. The...
This federal contract award was made to Biogen U.S. Corporation, a pharmaceutical and biotechnology company, by the Department of Veterans Affairs (VA) for the supply of the drug QALSODY (tofersen). The award is a delivery order placed against Biogen's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract, with a ceiling value of $32,607.45 and a period of performance through September 30, 2024. The contract does not have a set-aside designation, indicating it was competed on the open...
This federal contract award is a delivery order for PHARMACY ADVATE ANTIHEMOPHILIC FACTOR, RECOMBINANT 2000UNT/VIL INJ, placed by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule. The prime contractor is Takeda Pharmaceuticals America Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $16,175.70 and no set-aside designation. This award represents a task order under a larger...
This federal contract award, valued at $43,476.60, was issued by the Department of Veterans Affairs (VA) to Biogen U.S. Corporation, a pharmaceutical and biotechnology company. The contract is a firm-fixed-price delivery order placed against Biogen's Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The contract is for the delivery of QALSODY (tofersen), a pharmaceutical product used to treat neurological conditions in veterans. This award does not carry a...
This is a federal contract award to Takeda Pharmaceuticals America Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The contract, valued at $9,378.72, is a delivery order placed under the General Services Administration (GSA) Pharmaceutical and Drugs Schedule (FSS-61-IB) contract. The award is for the supply of two specialized pharmaceutical products: NDC 64764-0800-56 MARIBAVIR 200MG TAB and LIVTENCITY 200MG TAB. The contract is a firm...
This federal contract award is for the delivery of QALSODY (TOFERSEN) 6.7MG SOLN (2 VIALS) NDC: 64406-0109-01 pharmaceutical product to the Department of Veterans Affairs (VA). The contract was awarded to Biogen U.S. Corporation, a subsidiary of Biogen Idec Incorporated, a biotechnology company focused on developing therapies for neurological diseases. The contract is a firm-fixed-price delivery order valued at $21,738.30, awarded against Biogen's Pharmaceuticals and Drugs General Services...
This federal contract award is for the delivery of FEIBA anti-inhibitor coagulant complex to the Veterans Integrated Service Network 21 (VISN 21), a part of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Takeda Pharmaceuticals America Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, on October 22, 2024. The award has a ceiling value of $27,451.20 and is a firm fixed-price delivery order issued against Takeda's existing...
This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit biotherapeutics company. The $83,607.60 firm fixed-price delivery order is for the supply of 3,000 units of the drug HAEGARDA to the James H. Quillen VA Medical Center and Nashville VA Medical Center. This award is made under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed price delivery order contract valued at $184,644.74 to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract, which is not set-aside, falls under Takeda's General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs. The primary products being delivered are the oncology medications ICLUSIG...
This federal contract award to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, is for the delivery of the oncology medication ICLUSIG (ponatinib) to the U.S. Department of Veterans Affairs (VA). The $27,913.44 firm-fixed-price delivery order is placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and has a completion date of September 19, 2024. The contract is not set aside and...